NCT Number: NCT02505035
Randomized Evaluation of Default Access to Palliative Services
This is a large pragmatic, randomized controlled trial to test the real-world effectiveness of inpatient palliative care consultative services in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The investigators hypothesize that improved patient-centered outcomes can be achieved without higher costs by simply changing the default option for inpatient palliative care consultation for eligible patients from an opt-in to an opt-out system. To test this hypothesis the investigators will conduct a clinical trial at 11 hospitals using the same electronic health record within Ascension Health, the largest non-profit health system in the U.S.
Looking for future studies?
Notify MeKey information
Conditions
Age range
65 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
St. Vincent's Medical Center, Bridgeport, Connecticut, United States
About this study
The REDAPS trial aims to generate large-scale, experimental evidence regarding the real-world effectiveness of inpatient palliative consultative services (IPCS) and to test the incremental effectiveness and costs of a simple, scalable method to increase IPCS utilization among properly selected patients. The REDAPS trial will also compare the effectiveness of different palliative care team structures and services and identify patient subgroups most likely to benefit from IPCS. To achieve these goals, the investigators will conduct a clinical trial at 11 Ascension Health hospitals using the same electronic health record. Participating hospitals first contribute a minimum of 4 months of data under the control paradigm (opt-in model), where physicians must identify patients who may benefit from palliative care consultation and actively order such services. Then, using a stepped-wedge design, the hospitals are randomly assigned to begin the intervention in intervals spaced approximately 2.7 months apart. During the intervention, patients meeting consensus criteria for eligibility for palliative care consultation are identified by the electronic health record, a consultation is ordered by default, physicians may cancel the order after being alerted to it, and patients or family members may decline such services. By the end of the trial, all hospitals will have utilized the intervention paradigm of palliative care consultation for at least 4 months. The REDAPS trial will compare outcomes (clinical, economic, and process measures) before and after implementation within hospitals, as well as comparisons among hospitals at given time points.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age 65 years or older
- Current hospitalization of at least 3 calendar days (modified ITT)
- Diagnosis of one or more of the following:
- End-stage renal disease (ESRD) on dialysis
- Chronic obstructive pulmonary disease (COPD) with home oxygen dependence or 2 or more hospitalizations in the past 12 months
- Dementia admitted from a long-term care facility or prior placement of a surgical feeding tube or 2 or more additional hospitalizations in the past 12 months
Exclusion criteria
- Patients younger than 65 years old will not receive the intervention
Treatment and study plan
Primary outcomes
-
Composite Measure: Length of Stay and In-Hospital Mortality
Time frame: Duration of hospital stay, an expected average of 8 days
The primary outcome is a composite measure of in-hospital mortality and hospital length-of-stay that ranks deaths along the length-of-stay distribution. Data is extracted from the electronic health record.
Secondary outcomes
-
Goals of care assessment
Time frame: Duration of hospital stay, an expected average of 8 days
Documented assessments of patients' goals of care within the electronic health record
-
Pain assessment
Time frame: Duration of hospital stay, an expected average of 8 days
Documented assessments of patients' pain scores within the electronic health record
-
Dyspnea assessment
Time frame: Duration of hospital stay, an expected average of 8 days
Documented assessments of patients' dyspnea within the electronic health record
-
Code status
Time frame: Duration of hospital stay, an expected average of 8 days
Code status documented within the electronic health record
-
Mechanical ventilation
Time frame: Duration of hospital stay, an expected average of 8 days
Documented orders for mechanical ventilation within the electronic health record
-
Cardiopulmonary resuscitation
Time frame: Duration of hospital stay, an expected average of 8 days
Documented orders for cardiopulmonary resuscitation within the electronic health record
-
Inpatient dialysis
Time frame: Duration of hospital stay, an expected average of 8 days
Documented orders for dialysis during inpatient stay within the electronic health record
-
ICU admission
Time frame: Duration of hospital stay, an expected average of 8 days
Transferal to an intensive care unit documented within the electronic health record
-
Hospital discharge status
Time frame: Duration of hospital stay, an expected average of 8 days
Hospital discharge disposition code documented within the electronic health record
-
Discharge planning orders
Time frame: Duration of hospital stay, an expected average of 8 days
Discharge orders for home care services documented within the electronic health record
-
Hospital readmission
Time frame: 30 days
30-day hospital re-admissions documented within the Premier database
-
Direct cost per day
Time frame: Duration of hospital stay, an expected average of 8 days
Direct cost per day documented within the Premier database
-
Direct cost per hospitalization
Time frame: Duration of hospital stay, an expected average of 8 days
Direct cost per hospitalization documented within the Premier database
Sponsors and collaborators
Lead sponsor
University of Pennsylvania
Other
Collaborators
- National Institute on Aging (NIA)
Registry information
Official study title
Default Palliative Care Consultation for Seriously Ill Hospitalized Patients
Acronym: REDAPS
Important dates
- Study start
- 2016
- Primary completion
- 2018
- Study completion
- 2020
- First posted
- Jul 22, 2015
- Registry last updated
- Sep 11, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study to Determine Therapeutic Massage Dosing to Improve Quality of Life in Hospitalized Patients Receiving Palliative Care
NCT04916223
Blood-Borne Infections, Brain Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsGoal Concordant Care Learning Laboratory
NCT05879211
Brain Diseases, COPD
Durham, North Carolina, United States
View Trial DetailsMeals MATTER: A Trial of Medically Tailored Meals 2 Weeks vs. 4 Weeks Post Hospital Discharge
NCT04351880
COPD, Cancer
Denver, Colorado, United States
View Trial DetailsA Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial Details